C

Cannabis Poland SA
WSE:CBD

Watchlist Manager
Cannabis Poland SA
WSE:CBD
Watchlist
Price: 0.301 PLN -5.94% Market Closed
Market Cap: 14.8m PLN
Have any thoughts about
Cannabis Poland SA?
Write Note

Operating Margin
Cannabis Poland SA

-726.6%
Current
-972%
Average
6.8%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-726.6%
=
Operating Profit
-2.1m
/
Revenue
287.8k

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
PL
Cannabis Poland SA
WSE:CBD
14.8m PLN
-727%
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY
-83%
US
Eli Lilly and Co
NYSE:LLY
756.2B USD
35%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
3%
DK
Novo Nordisk A/S
CSE:NOVO B
2.7T DKK
44%
US
Johnson & Johnson
NYSE:JNJ
351.2B USD
28%
US
Merck & Co Inc
NYSE:MRK
251.2B USD
34%
CH
Roche Holding AG
SIX:ROG
200.1B CHF
32%
UK
AstraZeneca PLC
LSE:AZN
161.8B GBP
21%
CH
Novartis AG
SIX:NOVN
171.5B CHF
31%
US
Pfizer Inc
NYSE:PFE
151.1B USD
22%
Country PL
Market Cap 14.8m PLN
Operating Margin
-727%
Country JP
Market Cap 776 550.9T JPY
Operating Margin
-83%
Country US
Market Cap 756.2B USD
Operating Margin
35%
Country UK
Market Cap 440.4B GBP
Operating Margin
3%
Country DK
Market Cap 2.7T DKK
Operating Margin
44%
Country US
Market Cap 351.2B USD
Operating Margin
28%
Country US
Market Cap 251.2B USD
Operating Margin
34%
Country CH
Market Cap 200.1B CHF
Operating Margin
32%
Country UK
Market Cap 161.8B GBP
Operating Margin
21%
Country CH
Market Cap 171.5B CHF
Operating Margin
31%
Country US
Market Cap 151.1B USD
Operating Margin
22%
No Stocks Found

Cannabis Poland SA
Glance View

Market Cap
14.8m PLN
Industry
Pharmaceuticals

Cannabis Poland SA engages in the production and distribution of cannabinoid vaporization equipment and oils. The company is headquartered in Warsaw, Woj. Mazowieckie. The company went IPO on 2013-04-09. The firm focuses on operating in the field of production and sale of pharmaceutical and medical products, with the main focus on vaporization products containing cannabinoids manufactured from cannabis. The firm also expands its activity to include other products than pharmaceuticals, such as cosmetics, oils containing cannabinoids for human and animals and photovoltaic cells. The firm is engaged in research and development of a Cannabidiol (CBD)/ Tetrahydrocannabinol-based (THC-based) pharmaceutical for use in the treatment of seizures associated with drug-resistant epilepsy.

CBD Intrinsic Value
0.016 PLN
Overvaluation 95%
Intrinsic Value
Price
C

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-726.6%
=
Operating Profit
-2.1m
/
Revenue
287.8k
What is the Operating Margin of Cannabis Poland SA?

Based on Cannabis Poland SA's most recent financial statements, the company has Operating Margin of -726.6%.